** Shares of Israel-based drug developer NTEC.O jump 20.9%
to $0.31 premarket, their highest level in more than one month
** Co says it entered into a research collaboration
agreement with Merck & Co MRK.N ; Says details of the agreement
are confidential urn:newsml:reuters.com:*:nPn8C9XfVa
** Stock set for its best day since late-July
** NTEC down 49.3% this year by its last close
(Reporting by Ambar Warrick in Bengaluru)
((Ambar.Warrick@thomsonreuters.com; +91-80-6182-2837; Reuters
Messaging: ambar.warrick.thomsonreuters.com@reuters.net;
Twitter: @AmbarWarrick))